Marina Bussel
Psychiatry · Playa Vista, CANPI 1689910390
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $662 of the $995 with a category attached, or 66.5%. 7 manufacturers reported payments, led by E.r. Squibb & Sons, L.L.C. at 44.9% of the total. 2025 is the largest year on record at $670, 5.7 times the $118 reported in 2019.
Across 24 payments — averaging $41.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$447
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$220
- Alkermes, Inc.$118
- Neurocrine Biosciences, Inc.$82
- Johnson & Johnson$64
- AbbVie$40
- plus $23 from 1 others
Across 1,103 payments — averaging $10,851 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$5.5M
- AbbVie$2.1M
- Sumitomo Pharma America, Inc.$1.1M
- Hoffmann-la Roche Limited$816K
- E.r. Squibb & Sons, L.L.C.$613K
- Teva Pharmaceuticals USA, Inc.$351K
- plus $1.4M from 22 others
What the payments were for
- Travel & lodging$33333%
- Food & beverage$66267%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 6 | $447 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $220 |
| Alkermes, Inc. | 1 | $118 |
| Neurocrine Biosciences, Inc. | 1 | $82 |
| Johnson & Johnson | 3 | $64 |
| AbbVie | 2 | $40 |
| Merck | 1 | $23 |
How this compares
$995 in reported general payments places this provider in the 75th percentile of 4,954 psychiatry providers in California.
Other psychiatry in Playa Vista
- Gustavo AlvaOrange$5.8M
- John KooSan Francisco$3M
- Jason KelloggIrvine$2.7M
- Jonathan MeyerSan Diego$2.3M
- Charles Tuan-Tu NguyenIrvine$2.1M
- Manoj WaikarLos Gatos$1.9M
- Gerald MaguireSan Juan Capistraco$1.8M
- Salima BrillmanSunnyvale$1.4M
- Bibi DasStanford$1.4M
- Konstantinos TripodisBurbank$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.